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ABSTRACT
CUGBP, Elav-like family member 1 (CELF1) is an
RNA binding protein with important roles in the
regulation of splicing, mRNA decay and translation.
CELF1 contains three RNA recognition motifs
(RRMs). We used gel retardation, gel filtration,
isothermal titration calorimetry and NMR titration
studies to investigate the recognition of RNA by
the first two RRMs of CELF1. NMR shows that
RRM1 is promiscuous in binding to both UGU and
CUG repeat sequences with comparable chemical
shift perturbations. In contrast, RRM2 shows greater
selectivity for UGUU rather than CUG motifs. A con-
struct (T187) containing both binding domains
(RRM1 and RRM2) was systematically studied for
interaction with tandem UGU RNA binding sites
with different length linker sequences UGU(U)xUGU
where x=1–7. A single U spacer results in inter-
actions only with RRM1, demonstrating both steric
constraints in accommodating both RRMs simultan-
eously at adjacent sites, and also subtle differences
in binding affinities between RRMs. However, high
affinity co-operative binding (Kd 0.4mM) is evident
for RNA sequences with x=2–4, but longer spacers
(x 5) lead to a 10-fold reduction in affinity. Our
analysis rationalizes the high affinity interaction of
T187 with the 11mer GRE consensus regulatory
sequence UGUUUGUUUGU and has significant con-
sequences for the prediction of CELF1 binding sites.
INTRODUCTION
CELF1, also known as CUG-BP1 or EDEN-BP, is a
member of the CELF/Bruno-like protein family, a group
of RNA binding proteins that is widely conserved in the
animal kingdom, both at the functional and the sequence
level (1–5). CELF1 and its relatives can regulate mRNA
function at the level of alternative splicing, translational
repression, translational activation, deadenylation and
destabilization (6–13). Up-regulation of CELF1 has
been linked to muscular dystrophy and ageing in
humans, while the CELF1 knockout mice suffer from
reduced viability, growth retardation and infertility
(14,15). CELF1 is ubiquitously expressed and has been
shown to regulate the expression of proteins involved in
somitic segmentation, muscle differentiation, cell prolif-
eration and the production of inﬂammatory cytokines,
and is therefore likely to be involved in a variety of im-
portant physiological and pathological cellular processes
(2,13,16–23).
Unmodiﬁed CELF1 has a low afﬁnity for CUG repeats
and binding studies indicate that its preferred substrates
are GU rich sequences, both in mammalian species and
for Xenopus (24–26). Recently, these GU rich elements
were identiﬁed as abundant targets of the CELF
proteins that function both in alternative splicing and in
mRNA destabilization (2,12,27,28). By bioinformatic
analysis, the sequence UGUUUGUUUGU was derived as
the consensus binding element (13,29). However, many
well characterized natural binding sequences consist of
more dispersed UGU repeats with apparent dissociation
constants of 3–100nM (7,13,18,24,29,30).
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strates that are characterized by GC rich sequences,
similar to the CUG repeat. CELF1 regulates the transla-
tion of these mRNAs by binding to their 50-UTRs.
Binding to substrates is enhanced by phosphorylation,
which may be why these binding sites have so far not
been identiﬁed in systematic screens of CELF1 substrates
(19,21,31,32).
The CELF proteins all have three RNA binding motifs
(RRMs), two at the N terminus and one at the C terminus
(Figure 1). The domains required for RNA binding of
CELF1 have been studied on multiple substrates
(25,31,33,34). Using a yeast three-hybrid approach, human
CELF1 was found to bind GU rich elements both by the
third RRM alone and by a construct from which the third
RRM was deleted. Smaller constructs containing RRM1
and RRM2 alone were not capable of binding to the RNA
(25). For Xenopus CELF1 [also called EDEN-BP based
upon the recognition of the Embryonic Deadenylation
ElemeNt (EDEN)], binding to a GU rich substrate
in vitro was found to depend solely on the ﬁrst two
RRMs and a portion of the linker region. This linker
region has also been implicated in the dimerization or
oligomerization of the protein (33,35). CUG binding of
CELF1 is also thought to be dependent on the highly
conserved ﬁrst two RRMs indicating that these domains
may convey dual speciﬁcity (34).
Recently structural studies were published for the third
RRM of human CELF1 and Drosophila Bruno (36,37).
These indicate that this RRM has an N-terminal extended
region and speciﬁcally binds UGU, but not CUG,
tri-nucleotides. We report here that the ﬁrst two RRMs
also speciﬁcally bind UGU tri-nucleotides independently
of the linker region between them. For both RRMs to
bind in tandem to an RNA molecule, the spacing (x)
between the tri-nucleotides in the UGUNxUGU recogni-
tion motif has to be  1nt, with x=2–5 demonstrating
effective binding to RRM1 and RRM2. From gel ﬁltra-
tion and Nuclear Magnetic Resonance (NMR) titration
studies, we are able to show that RRM1 and RRM2
have different afﬁnities and speciﬁcities for UGU and
CUG/UGC motifs. These data lead to a new consensus
binding sequence for CELF1.
MATERIALS AND METHODS
Cloning and expression
Full length coding sequences of Xenopus CELF1 were ob-
tained by RT–PCR on oocyte RNA, using primers on the
start and stop codons. The primers added Xho1 and Nhe1
sites to allow cloning in pET28a. Sequencing revealed that
the isoform A was identical to the coding region in
NM_001090727.1, isoform B to NM_001086501.1 and
isoform C had the same insertion as EST DC055829.1,
but was otherwise identical to isoform A. The DNA of
the T187 construct was cloned into the pET-28a expres-
sion vector (Novagen), in fusion with an N-terminal
His-tag and thrombin cleavage site. The RRM1 construct
was produced by point mutation of Asn102 to a stop
codon. The RRM2 DNA sequence was cloned into the
NheI/HindIII site of pET28a. All proteins were overex-
pressed in Escherichia coli BL21 (DE3) cells grown in
Luria Broth in the case of unlabelled material, and M9
minimal media for the production of
15N- and
13C-labelled
material. All media was treated with 30mg/ml kanamycin.
Protein expression was induced for 16h at 30 C.
Harvested cells were lysed by sonication in 25mM potas-
sium phosphate, 50mM NaCl, pH 7.0 buffer. A protease
inhibitor cocktail (Roche) was added immediately before
sonication.
After centrifugation to remove cell debris, the lysate was
applied to a His-tag binding cobalt column (TALON) and
allowed to bind for 2h. After binding the beads were
washed with 25ml of high salt buffer (2M NaCl, 25mM
potassium phosphate, pH 7.0), followed by 25ml of
10mM imidazole. The protein was eluted with 500mM
imidazole, 25mM potassium phosphate, 50mM NaCl).
The His-tag was removed by an overnight incubation
with thrombin at room temperature. T187, RRM1 and
RRM2 were all puriﬁed by gel ﬁltration (Superdex 75),
followed by desalting into water on a HiTrap desalting
column (Amersham Biosciences). Protein was lyophilized
immediately after desalting.
UV crosslinking and gel retardation
The maskin 30-UTR (Msk) and the xxsB1 plasmids, RNA
probe synthesis from them and UV crosslinking with
RNase digestion have been described previously (38).
For gel retardation, the RNAs oligonucleotides
synthesized by Dharmacon were end-labelled with
[g-
32P]-ATP (PerkinElmer Life Sciences) and T4 poly-
nucleotide kinase (NEB) in 10ml for 30min at 37 C.
After denaturation at 90 C for 3min, 1ml of RNA was
Figure 1. Schematic representation of the protein constructs used in
this study and an indication of domain boundaries. The position of
the RRMs are shown shaded. Residue Ser28 represents the proposed
Akt phosporylation site in RRM1.
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centrations in buffer A (12.5mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.9, 5mM
MgCl2, 15% glycerol, 1mM EDTA, 5mg/ml BSA,
0.025% NP40, 80mM NaCl, 0.2mg/ml heparin, 100ng/
ml poly I/C) or B (20mM HEPES, pH 7.0, 2mM MgCl2,
5mM DTT, 100mM KCl, 0.2mg/ml heparin, 1mg/ml
tRNA) to achieve ratios of RNA: protein from 1:0 to
1:100. Binding reactions (10ml) were incubated for
10min, and native gel electrophoresis was used to separate
bound and free RNA species as described previously (39).
Gel ﬁltration
The RNA oligonucleotides (Dharmacon) were dissolved
in RNase free H2O, to make a 7-mM solution. The
RNAs were denatured for 3min at 90 C then placed on
ice for another 3min to remove any secondary structure.
RNAs were incubated with the protein (1:1 ratio) in buffer
for 10min at room temperature. A 250mL volume of
protein solution, RNA solution or protein–RNA
complex were loaded on a Gel ﬁltration Superdex 75 10/
300 column (Amersham Biosciences) at 4 C. The ﬁnal pro-
tein concentration was 50mM for all experiments and the
ﬁnal RNA concentration 50mM for a 1:1 ratio and was
altered to achieve the different ratios in each case. The
column was pre-equilibrated and run in 25mM HEPES
pH 7.0, 50mM NaCl at 0.5ml/ml.
NMR spectroscopy
NMR samples were prepared by dissolving lyophilized
protein in 600ml of 25mM potassium phosphate, 50mM
NaCl, pH 7.0, 10% D2O (v/v). All experiments were
carried out at 25 C on a 600MHz Bruker Avance spec-
trometer. A protein concentration of 1mM was used in
the collection of 3D data. An amount of 400–500mM
protein samples were used in the RNA titrations, with
RNA added from a 7mM concentrated stock over the
course of the titration. The RNA was supplied by
Dharmacon.
1H/
15N-TROSY spectra were collected at
each titration point, with the titration being terminated
when no further variation was seen. Backbone assign-
ments of the T187, RRM1 and RRM2 constructs were
obtained using
1H/
15N-HSQCs, and triple resonance
experiments (NHCO, NHCACO, CBCANH,
CBCACONH). Data was processed using Topspin 2.1
and analysed in CCPNMR Analysis. Heteronuclear
1H/
15N Nuclear Overhauser Effect (NOE) data were col-
lected on an 800MHz spectrometer with ultrashield
magnet and cryoprobe facility.
Isothermal titration calorimetry
ITC measurements were collected using a Microcal
VP-ITC calorimeter. All experiments were performed at
25 C. Samples were dissolved in degassed RNase free
water. An amount of 25mM RNA solutions were prepared
in the cell, and a 250mM solution of the protein injected
from the syringe. The titration consisted of 30 injections of
10ml each at 5-min intervals. Data was analysed using the
Microcal ORIGIN software.
Mass spectrometry
All ESI mass spectra were collected on a Waters SYNAPT
instrument with a quadruple time-of-ﬂight mass analyser
calibrated using horse heart myoglobin. The Masslynx
TM
(Waters) software was used to acquire and analyse the
data. Samples were prepared by dissolving lyophilized
protein in water and then desalting into 50mM
ammonium acetate through a HiTrap desalting column
(Amersham Biosciences). RNA was added by injection
of small amounts from a stock solution of 7mM RNA
in RNase-free water. Samples were injected at 5ml/min.
Data for some RNA–protein complexes required collec-
tion in negative ion mode.
RESULTS
CELF1 constructs and UV cross-linking
In order to study the structure and RNA binding
properties of CELF1, we ampliﬁed the Xenopus CELF1
coding region from oocyte cDNA and cloned it into a
bacterial expression vector. To deﬁne the minimum re-
quirement for speciﬁc RNA binding in the N terminal
RRMs of CELF1 we prepared His-tagged bacterial ex-
pression constructs to produce individual and multiple
domains of the original Xenopus CELF1, as indicated
schematically in Figure 1 and as SDS–PAGE in
Supplementary Figure S1. Earlier reports indicated that
the ﬁrst 353 amino acids were required for binding (termed
T353), so we initiated our studies with the T353 construct
and the full length expression clone (35). As shown in
Figure 2a, the puriﬁed proteins showed efﬁcient UV
crosslinking to a high afﬁnity natural substrate, the
maskin 30-UTR, as well as reduced efﬁciency to a low
afﬁnity substrate, a short section of the cyclin B1
30-UTR (40). Under the conditions used, little cross-
linking was observed with a control RNA. Surprisingly,
a minor degradation product of the T353 protein of
 25kDa also cross-linked to both the high and the low
afﬁnity substrates (data not shown). This demonstrates
that the linker region is not an absolute requirement for
speciﬁc binding and it encouraged us to try some of the
shorter constructs. In Figure 2b UV crosslinking experi-
ments show the maskin 30-UTR interaction with a con-
struct spanning residues 1–187 (T187) was completely
competed out using synthetic EDEN15 RNA at ratios of
1:5, while no crosslinking was detected with a control
RNA (Bluescript). These data demonstrate that the T187
region containing the ﬁrst two RRMs binds RNA with a
high speciﬁcity.
CELF1 RNA complex formation measured using gel shift
and gel ﬁltration
We designed a series of synthetic RNAs (Table 1) based
on the reported binding sequences of CELF1 and tested
binding using gel shift, gel ﬁltration and mass spectrom-
etry. In a gel shift assay, the T187 protein bound well to
the consensus EDEN sequence (EDEN15, also known as
the GRE or the UGUU repeat), forming three different
complexes (Figure 2c). EDEN11, which lacks one repeat,
8640 Nucleic Acids Research, 2011,Vol.39, No. 19formed similar complexes at similar protein concentra-
tions. In contrast, EDEN7 (UGUUUGU) only formed
small amounts of complex at much higher concentrations
of protein indicating that EDEN11 contains the minimal
optimal binding site. No complex formation was observed
with an AU rich element (Figure 2c). The GUCU repeat,
which is present in the Maskin 30-UTR, also gave efﬁcient
gel shifts, while the EDEN19 sequence from the c-Mos
mRNA bound only weakly, if at all (Figure 2d and e).
These data indicate that T187, as has been reported for
the full length protein, binds to UGU rich sequences, but
that the context is not optimal in EDEN19 and that
EDEN7 does not contain a full binding sequence.
We next performed gel ﬁltration experiments using an
analytic Superdex 75 column to detect CELF1 RNA
complex formation and characterize stoichiometry of
binding. The column was calibrated using known molecu-
lar weight standards. Table 2 shows the results for the
T187 construct and isolated RRM1 and RRM2 domains
showing complexes formed with a variety of RNAs which
were also analysed in isolation. T187, RRM1 and RRM2
elute at slightly higher values (28.2, 18.5, 13.3kDa) than
their calculated molecular weights (21.7, 12.1, 9.6kDa re-
spectively) probably reﬂecting the elongated shape.
Consistent with gel shift experiments no complex forma-
tion was observed for these constructs when mixed at a 1:1
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Figure 2. The ﬁrst 187 amino acids of CELF1 are sufﬁcient for speciﬁc binding to natural and synthetic binding sites. (a) UV-crosslinking of BSA
control (C), full length CELF1 (FL), T353 (T) with radioactive maskin 30-UTR (Msk), a truncated cyclinB1 30-UTR (xxsB1) and a Control RNA
(Bluescript polylinker transcript). Sizes of crosslinked bands are indicated. (b) UV-Crosslinking competition assay. The maskin 30-UTR was
competed with synthetic EDEN15. Radioactive control RNA (Bluescript: BS) or maskin 30-UTR with EDEN15 in the indicated molar ratios
were incubated with T187 and covalently crosslinked using by UV light. (c) Gel retardation assay with T187 EDEN15, EDEN11 and EDEN7,
as well as with the AU rich element (ARE15) incubated in buffer A. An amount of 50nM of RNA end labelled with g-P
32-ATP was incubated with
increasing concentration of t187 protein, ratio RNA: protein from 1:0 to 1:100. Slender arrows indicate free RNA, thick arrows complexes induced
by the protein. (d) Gel retardation of 45nM GUCU15 with increasing concentrations of T187 in buffer B. (e) Gel retardation of 45nM EDEN19
with increasing concentrations of T187 in buffer B.
Nucleic Acids Research, 2011,Vol.39, No. 19 8641molar ratio with the ARE7 RNA. The results for T187
and EDEN15 also conﬁrmed the observations from the
gel shift assays and two different complexes of weights
42.5 and 59.2kDa are clearly separated from a 1:1 molar
mixture. With an excess of protein (1:0.25 ratio) the larger
complex predominates indicating there are likely two
binding sites for T187 on EDEN15. An excess of RNA
results in the smaller complex in isolation representing a
1:1 complex. Speculative schematic models representing
how the RRMs might engage the UGUs on EDEN15
are illustrated together with the gel ﬁltration proﬁle in
Figure 3a. We also observed complex formation between
T187 and RNAs GU15, CUG15.
Gel ﬁltration also successfully identiﬁed complexes for
RRM1 and RRM2 with the EDEN7 RNA. In the case of
RRM2 the calculated weight of 20.7kDa is consistent with
a 1:1 complex. Unexpectedly, identical experiments with
RRM1 resulted in a larger weight of 29.5kDa suggestive
of a 2:1 complex. This is perhaps not so surprising as
EDEN7 contains two UGU motifs. To test this we
designed RNA with sequence UGUUUAU termed
EDEN7
m intended to disrupt the second UGU binding
site. The size of the RRM1:EDEN7
m complex was then
signiﬁcantly reduced to 23.7kDa consistent with a 1:1
complex. A titration of different ratios of RRM1 and
EDEN7 is illustrated in Figure 3b but unlike similar ex-
periments with T187 and EDEN15 no 1:1 complex is
detected. Similarly, mass spectrometry of an RRM1/
EDEN9 mixture showed two species of mass 12174 and
27 118. The RRM1 construct has a theoretical mass of 12
182.8, and EDEN9 plus two molecules of RRM1 has a
calculated mass of 27 135.6, consistent with the observed
species. No peak representing the 1:1 complex was
observed (Supplementary Data).
RRM1
EDEN7
1:0.25
1:2
T187
EDEN15
(a)
15 20 17.5 12.5
15 17.5 10 12.5
(b)
1:1
Figure 3. CELF1 RNA complex gel ﬁltration proﬁles. (a) Plot of UV
absorbance versus elution volume for T187 protein (blue) with RNA
EDEN15 (red) mixed at two different molar ratios, 1:0.25 (pink); 1:1
(green), 1:2 (turquoise). (b) CELF1 RRM1 RNA complex gel ﬁltration
proﬁles. In blue RRM1 and in red EDEN7 alone. Different ratios
RRM1:EDEN7: 1:0.25 (pink); 1:0.5 (orange); 1:1 (green) and 1:2
(turquoise).
Table 2. Summary of gel ﬁltration experiments with synthetic RNA
and recombinant CELF1 constructs
Protein/RNA sample Elution
volume
(ml)
MW
(kDa)
Complex Stoichio-
metry
T187 (21.7kDa) 12.5 28.2 – –
T187/EDEN15 11.2,10.3 42.5,59.2 Y 1:1, 2:1
T187/EDEN11 11.4 40.3 Y 1:1
T187/EDEN9 11.5 39.0 Y 1:1
T187/EDEN7 11.7 36.4 Y 1:1
T187/EDEN7
m 12.0 33.4 Y 1:1
T187/CUG15 11.5 38.9 Y 1:1
T187/GU15 11.2,10.4 43.1,56.2 Y 1:1, 2:1
T187/ARE7 12.5 28.2 N –
RRM1 (12.1kDa) 13.7 18.5 – –
RRM1/EDEN7 12.3 29.5 Y 2:1
RRM1/(UG)3 13.0 23.3 Y 1:1
RRM1/EDEN7
m 13.0 23.7 Y 1:1
RRM1/ARE7 13.6 19.0 N –
RRM2 (9.6kDa) 14.7 13.3 – –
RRM2/EDEN7 13.4 20.7 Y 1:1
RRM2/ARE7 14.6 14.0 N –
EDEN15 13.3 21.5
EDEN11 13.9 17.4
EDEN7 14.9 12.4
EDEN7
m 14.9 12.4
ARE7 14.8 12.7
(UG)3 15.8 9.3
Table 1. RNA sequences
RNA name Sequence
EDEN19 UGUAUGUGUUGUUUUAUGU
EDEN15 UGUUUGUUUGUUUGU
EDEN11 UGUUUGUUUGU
EDEN9 UUGUUUGUU
EDEN7 UGUUUGU
EDEN7m UGUUUAU
EDEN6 UGUUUG
GUCU15 UGUCUGUCUGUCUGU
CUG15 CUGCUGCUGCUGCUG
CUG2 CUGCUG
ARE15 UAUUUAUUUAUUUAU
ARE7 UAUUUAU
UG7 UGUGUGU
UG15 UGUGUGUGUGUGUGU
EDEN7 sequences (UGU(U)xUGU)
EDEN7 (x=1) UGUUUGU
EDEN2U (x=2) UGUUUUGU
EDEN3U (x=3) UGUUUUUGU
EDEN4U (x=4) UGUUUUUUGU
EDEN5U (x=5) UGUUUUUUUGU
EDEN6U (x=6) UGUUUUUUUUGU
EDEN7U (x=7) UGUUUUUUUUUGU
Potential RRM binding sites underlined.
8642 Nucleic Acids Research, 2011,Vol.39, No. 19NMR analysis of protein-RNA interactions for the
isolated RRM1 and RRM2
We performed 2D and 3D multi-dimensional NMR spec-
troscopy on both singly (
15N) and doubly labelled
(
13C/
15N) samples of recombinant RRM1, RRM2 and
T187 all of which were soluble in the 0.2–1.0mM concen-
tration range and gave concentration-independent NMR
spectra. The initial assignment of the two individual
RRMs greatly facilitated the analysis of the longer T187
construct which contains 12 proline residues. Ninety-three
percent of the non-proline backbone NH resonances (
1H
and
15N) of T187 could be assigned, with the unassigned
residues located largely within the disordered N-terminus
of RRM1. We further examined protein dynamics by
measuring
1H/
15N NOEs (Supplementary Data). Within
the folded RRMs of T187 the NOEs are typically  0.7,
consistent with compact globular structures. However,
residues within the loop sequence between strands b2
and b3 of RRM1, and those within the linker sequence
between domains (98–105), show a signiﬁcant reduction in
heteronuclear NOE (<0.6), with residues 100–102 in par-
ticular showing evidence for considerable ﬂexibility
(NOE<0.3).
Superposition of the
1H/
15N 2D TROSY spectrum of
T187 with ﬁrst RRM1 and then RRM2 shows the
spectrum of T187 to be well approximated as the sum of
those of RRM1 and RRM2 (Figure 4), with differences
localized to residues 100 and 101 in RRM1, 108 and 109 in
RRM2 which lie at the domain boundaries. The data are
consistent with a structural representation of T187 as two
independent folded domains connected via a ﬂexible
linker. We also examined a longer construct T242 which
contains a portion of the C-terminal linker region between
RRMs 2. The TROSY spectrum for T242 is very similar
to that of T187, but reveals that the additional  50 cross
peaks have narrow line widths and generally poor
chemical shift dispersion, indicative of a random coil,
ﬂexible C-terminal tail.
Sequence alignment with other RRMs reveals that
RRM1 and RRM2 of CELF1 have some unusual features.
Both RRMs have many of the well-conserved aromatic
residues on strands 1 and 3 found in other RRMs (F19,
F63 and F66 in RRM1 and F110, F152 and F155 in
RRM2). However, a unique feature is a Cys substitution
in place of a Phe for both RRM1 and RRM2 at residues
C61 and C150 respectively. To elucidate the RRM binding
speciﬁcity, we studied the
1H/
15N chemical shift perturb-
ations (CSPs) induced by RNA binding by ﬁrst consider-
ing the interactions of the individual RRMs. The EDEN7
RNA sequence (UGUUUGU) was titrated into a 0.5-mM
solution of RRM1 at pH 7.0 and CSPs were detected from
a series of 2D
1H/
15N-TROSY spectra collected at differ-
ent molar ratios (Figure 5a). Perturbations to the spectra
were manifest as either RNA concentration-dependent
fast-exchange movement of TROSY cross-peaks or
intermediate-exchange effects which resulted in the
movement, broadening and disappearance of peaks at
high RNA:protein ratios such that the bound state was
difﬁcult to identify. As a consequence, it was possible to
track the chemical shift changes between free and bound
states for some residues but not others. In Figure 5a–d,
measured CSPs are shown as black bars, but resonances
which broaden and disappear are shown with arrow
heads. In the titration of RRM1 with EDEN7, residues
in the b-strands undergo a combination of these effects.
In b1 (F19 and G21) and b3 (K59, C61 and C62) the CSPs
can be monitored, however, peaks for V20, V23, F63 were
rapidly lost. The perturbations readily conﬁrm that
RRM1 is interacting strongly with EDEN7 largely
through b1 and b3, with additional interactions with the
adjacent loops and residues within b4. Perturbations are
mapped on to the surface of the structure in Figure 6a.
The construction of binding isotherms from cross-peaks in
fast exchange suggest tight binding (Kd<10mM).
Fluorescence analysis at protein concentrations of 5 and
2.5mM produced steep binding curves saturating at close
to 1:1, similarly suggesting binding afﬁnities in the low
micromolar range.
Similar perturbations were observed for the binding of
RRM2 to EDEN7, with signiﬁcant CSPs in b1 for I112,
G113 and V115, and in b3 for C150, A151 and F152 with
the peaks for M114, K117, N118 rapidly lost (Figures 5b
Figure 4. 2D
1H/
15N-TROSY NMR spectra of T187 (a) and overlayed
spectra of RRM1 (red) and RRM2 (blue) in (b) showing that the longer
construct is well represented by the sum of the spectra of the individual
domains, except for a few perturbations at the domain boundaries.
Spectra were collected at 298K in 25mM phosphate buffer, 50mM
NaCl, 10% D2O (v/v), pH 7.0 with protein sample concentrations in
the range 400–500mM.
Nucleic Acids Research, 2011,Vol.39, No. 19 8643and 6b). Again, residues in b4 and the preceding loop
(V182 and A186) are also affected. The location and mag-
nitude of the shifts suggest that the RNA–protein inter-
actions are quite similar for both RRMs. However, some
differences in the binding stoichiometries are readily
apparent that are consistent with gel ﬁltration studies
(Figure 3). In the NMR titration studies with RRM1
and EDEN7, the CSPs reach a limiting value at a molar
ratio close to 1:0.5 (RRM1:EDEN7) which suggests that
two RRM1s can be accommodated on the EDEN7 UGU
repeat sequence. ESI-MS data conﬁrm that the 2:1
complex is also highly abundant in the gas phase. In
contrast, NMR titration studies with RRM2 indicate
that saturation of binding occurs much closer to a 1:1
ratio. We explored this further in titration studies with
UGUUUAU and a UGU trinucleotide where only a
single UGU site was available. Both of these RNA sub-
strates gave similar NMR CSPs to those observed for
EDEN7, with limiting shifts at a 1:1 ratio. A control
sequence UAUUUAU (ARE) lacking a suitable UGU
site did not cause signiﬁcant CSPs. The data clearly indi-
cate that RRM1 binds to a minimal UGU trinucleotide
and that two RRM1s are accommodated on EDEN7 con-
taining a UGU repeat.
We extended the analysis to the binding of RRM1 and
RRM2 to CUG repeat sequences by titrating the proteins
with CUGCUG. As can be seen (Figure 5c and d), RRM1
gave a similar pattern and magnitude of CSPs to those
described for the interaction with EDEN7, however, a
few additional peaks (V23) remained visible throughout
the titration. RRM1 appears to be promiscuous in
binding both the CUGCUG and UGUUUGU sequences
using the same b-sheet binding surface, however, there are
some subtle differences in the CSPs for the complexes with
EDEN7 and CUGCUG. In a few cases, the direction
of the movement of cross-peaks and the magnitude
of the change suggest sequence speciﬁc binding effects.
In contrast, RRM2 did not give clear CSPs with the CU
GCUG RNA, with few CSPs observed over 0.1ppm
(Figure 5d), indicating a much lower afﬁnity interaction.
Tandem interaction of RRM1 and RRM2 of T187
We examined the tandem interaction of RRM1 and
RRM2 with RNA in the context of the longer construct
T187 in which the two RRMs are covalently connected
through an eight-residue ﬂexible linker. With NMR as-
signments for >90% of residues we could monitor inter-
actions with both RRMs simultaneously. Titration with
Figure 5. NMR CSP plots for the binding of EDEN 7 (UGUUUGU) and CUGCUG to the two isolated RRMs. In (a) and (b), EDEN7 binding to
RRM1 is illustrated, and in (c) and (d), binding of CUGCUG to RRM1 and RRM2. In each case an arbitrary cut-off of 0.1ppm is shown by the
dotted line with residues showing CSPs>0.1ppm individually labelled. In addition, proline residues are marked with a black dot and residues which
broaden and disappear during the titration are marked with an arrow head. Along the top of the ﬁgure the relative position of the protein secondary
structure is indicated.
8644 Nucleic Acids Research, 2011,Vol.39, No. 19EDEN7 resulted in signiﬁcant perturbations to the reson-
ances of RRM1 but essentially no effects on the cross-
peaks from RRM2. The majority of the perturbed reson-
ances in the N-terminal RRM1 broadened and dis-
appeared, making quantitative analysis of CSPs difﬁcult.
These are plotted on to the structure shown in Figure 6c.
Two conclusions are immediately apparent: ﬁrst, RRM1
appears to bind with higher afﬁnity to the EDEN7
sequence than RRM2, such that the latter is not able to
compete effectively for binding sites. Secondly, EDEN7
appears to be too short to bind both RRMs simultaneously,
suggesting a critical minimum spacing between UGU sites
that is sterically compatible with both motifs being
accommodated at adjacent sites within a UGU repeat.
We examined this hypothesis using the longer EDEN11
(UGUUUGUUUGU) and EDEN15 sequences (UGUU
UGUUUGUUUGU). NMR analysis now showed signiﬁ-
cant CSPs for both RRMs of T187, with the magnitude
Figure 6. Structural representation of the CSPs mapped to the surface of the RRM1 (a), RRM2 (b) and T187 (c, d) for the RNA indicated. The
magnitude of the CSPs is shown on a red to grey scale (largest perturbations shown in brightest red). Residues which broaden and disappear are
marked in yellow, as particularly evident for the RRM1 domain of T187 on binding EDEN7.
Nucleic Acids Research, 2011,Vol.39, No. 19 8645of the effects comparable to those observed in the titra-
tions of the individual domains (Figure 7a; T187 with
EDEN15). Several additional key residues of T187,
including C61 in RRM1 and V115 in RRM2 now broad-
en and disappear, suggesting an enhanced interaction.
These RNA sequences demonstrate that a spacing of
5nt enables both RRMs of T187 to engage in tandem.
The perturbations are mapped on to the surface of
RRM1, RRM2 and T187 in Figure 6d, with the depth
of shading indicating the magnitude of the perturbations.
We examined the importance of the length of the spacer
sequence between UGU sites more systematically in NMR
titration studies with UGU(U)xUGU, where x=1–7
(Table 1). The magnitude of the CSP for C150 (RRM2)
in
1H/
15N TROSY spectra at binding saturation provided
an indicator of the relative binding afﬁnities, reaching a
plateau between x=2–5. Residues G113, A151 and F152
within RRM2 showed a similar behaviour but with
smaller limiting CSPs. However, longer U spacers (x=6
and 7) appeared to show a fall-off in binding interaction
with RRM2. In contrast, C61 of RRM1 showed the same
limiting shift in all cases (Figure 7f), suggesting that
RRM1 binds with higher afﬁnity and is anchored to the
ﬁrst UGU site to guide RRM2 into place. As described,
the very short spacer (x=1; EDEN7) is unable to accom-
modate both RRMs simultaneously and only RRM1
shows evidence of a signiﬁcant binding interaction.
Using the high afﬁnity EDEN4U sequence (x=4), we
also examined whether RNA binding resulted in signiﬁ-
cant changes in dynamics between the two RRMs of T187
by measuring
1H-
15N NOEs (as described above). Where
we could resolve the overlapping resonances, we could still
detect a smaller heteronuclear NOE for residues 99–101
(NOE 0.5) (Supplementary Data) which suggests that
some of the intrinsic ﬂexibility in the linker is retained in
the RNA-bound state of T187 of > 100-fold.
We examined a number of the UGU(U)xUGU se-
quences by ITC by titrating T187 into RNA to obtain
quantitative binding data (Figure 7g). EDEN7 (x=1) is
clearly different from the other sequences showing two
distinct sequential binding events. However, for x 2 the
binding isotherms are consistent with a single co-operative
binding interaction for T187 with Kd values in the range
0.4–4mM (Table 3), with similar enthalpies and entropies
of interaction (H=–45±2kJ mol
 1 and S=–125±
5JK
 1mol
 1). The highest afﬁnity interactions of
 0.4mM are evident for the shorter RNA sequences
(x=2 and 4), with a subsequent 10-fold reduction in
binding afﬁnity for the longer sequences (x=5 and 6),
broadly reﬂecting the results of the NMR titration studies.
In contrast, ITC studies of T187 with the trinucleotide
UGU demonstrated a weaker interaction with a Kd=
64±2mM, indicating a substantial enhancement of
binding afﬁnity from the co-operative interaction of the
two binding motifs of T187.
We also investigated the longer EDEN15 (UGUUUGU
UUGUUUGU) sequence by ITC, however, this produced
a more complex binding isotherm with at least two se-
quential binding events with quite different binding
afﬁnities (data not shown). The quality of the ﬁt to this
simple model was poor suggesting that there could be a
number of other degenerate 2:1 binding modes with regard
to positioning and orientation on the RNA. However, we
can rationalize the overall 2:1 binding stoichiometry on
the basis that RRM1 and RRM2 of T187 can bind in
tandem with high afﬁnity to two of the UGU sites of
EDEN15, with an optimal spacing of 5nt (underlined),
with a second molecule of T187 interacting at the
terminal UGU site (bold) only through its RRM1. The
observations from NMR titrations and ESI-MS experi-
ments that EDEN7 (UGUUUGU) can accommodate
two isolated RRM1s on the two closely spaced UGU
sites, suggest that this may also be a plausible model for
accommodating two T187 molecules in sequential binding
events with EDEN15, with the optimum 5-nt spacer
between UGU sites for accommodating in tandem the
RRMs of T187. ESI-MS analysis of the T187 interaction
with EDEN11 (UGUUUGUUUGU) unambiguously
conﬁrms a single high afﬁnity 1:1 complex.
We repeated the NMR titrations of T187 with the
CUG-rich sequence CUG15 (Figure 7b) and, surprisingly,
found that the CSP effects for RRM1 were reduced
compared to shifts of the isolated RRM1 with CUGCU
G. The perturbations to RRM2 all fell below the 0.1ppm
CSP cut-off, consistent with the weak interaction apparent
in the titration of the isolated domain with CUGCUG.
Speciﬁc effects in the TROSY spectra are illustrated for
residue C150 (RRM2) in which a large CSP is evident in
the titration with EDEN15, but no signiﬁcant effect is
observed with CUG15 (Figure 7c and d). The apparent
reduction in CSP effects for RRM1 when the two domains
bind in tandem suggests that RRM2 may exert some
negative allosteric regulation on the binding of RRM1
to CUG sequences.
DISCUSSION
We have demonstrated that the ﬁrst two RNA recognition
motifs (RRM1 and RRM2) of CELF1 are capable of bind-
ing independently to a single UGU site. Signiﬁcantly,
RRM1, but not RRM2, is also capable of binding to
CUG repeats, which when abnormally extended are
linked to a variety of pathological processes including
type 1 myotonic dystrophy (14,15). We have shown that
the shortest sequence studied with tandem UGU binding
sites (UGUUUGU: EDEN7) was able to accommodate
two RRM1s, but only a single RRM2 (Figure 8a). In
this context, RRM1 appears to recognize each UGU as
an independent site, from which we conclude that there is
no absolute requirement for a fourth nucleotide for bind-
ing. However, the observation that only a single RRM2
can be accommodated on this short RNA suggests that a
fourth nucleotide is a prerequisite for RRM2 with binding
to a 50-UGUU site.
We extended our analysis to the tandem recognition of
UGU(U) sites by RRM1 and RRM2 in a single protein
construct (T187) using a UGU(U)xUGU expansion series
of RNA sequences to investigate the effects of spacer
length between binding sites. We could ﬁnd no evidence
by NMR for the simultaneous binding of both motifs to
the shortest UGUUUGU (x=1) sequence, only
8646 Nucleic Acids Research, 2011,Vol.39, No. 19Figure 7. NMR CSP plots for the binding of EDEN15 (a) and CUG15 (b) to T187. In each case an arbitrary cut-off of 0.1ppm is shown by the
dotted line with residues showing CSPs>0.1ppm individually labelled. In addition, residues which broaden and disappear during the titration are
marked with an arrow head. No assignments were obtained for proline residues and these are marked with a black dot. Along the top of the ﬁgure
the relative position of the protein secondary structure is indicated with the domain boundary between RRM1 and RRM2 shown at residue 110.
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(continued)interactions with RRM1 (Figure 8b), suggesting that there
are signiﬁcant steric restraints in accommodating two
RRMs at two UGU(U) sites with only a single U
spacer. However, tandem high-afﬁnity binding inter-
actions where apparent for longer spacers (x=2–5nt)
without signiﬁcant apparent changes in afﬁnity (Figure
8c). The RRM2 interaction, but not RRM1, diminishes
for longer sequences (x=6 and 7), suggesting that RRM2
is transported into position on the back of its stronger
binding partner. Quantitative analysis by ITC shows a
high afﬁnity interaction ( 0.4mM) for the shorter se-
quences (x=2–4) in particular, and a 10-fold reduction
in binding afﬁnity for UGU sites that are more dispersed.
Furthermore, we are able to comment on the orienta-
tional preference for the binding of T187 to the two
UGU(U) sites in tandem on a single nucleotide chain.
Within the context of our UGU(U)xUGU expansion
series, the apparent preference of RRM2 for a UGUU
site suggests that it is accommodated at the 50-terminus
with RRM1 binding to the 30-end of the sequence. The
differences in stoichiometries that we observe for RRM1
and RRM2 binding independently to UGUUUGU are
consistent with this analysis. On this basis, we can con-
clude that the GU-rich GRE consensus regulatory se-
quence UGUUUGUUUGU (EDEN11), which has been
shown to mediate rapid decay of a number of GRE-
containing transcripts in primary human T-cells, binds
speciﬁcally through tandem interactions of RRM1 and
RRM2 of CELF1 at a unique site (Figure 9c). The inter-
action exploits both site preferences for UGU(U) and
spacer length (x=5) for a tandem interaction. In
addition, the EDEN15 RNA motif, which is the
over-represented 30-UTR target sequence for Xenopus
CELF1 (EDEN-BP) and activates deadenylation and sub-
sequent translational repression of EDEN-containing
transcripts, contains four copies of the UGU motif and
gives rise to two degenerate high afﬁnity sites each analo-
gous to that of the GRE sequence.
The apparent tolerance to different spacings between
UGU(U) binding sites while retaining a high afﬁnity inter-
action indicates that the two RRMs are ﬂexibly linked
with independent dynamics evident in the absence of
bound RNA. The two motifs appear to accommodate
either a short RNA sequence (x=2 or 3) in a linear tra-
jectory between RRMs, or form a looped-out conform-
ation with longer RNA spacer sequences (x>4). We
were unable to detect by NMR in titration studies any
differences in the interaction with RNAs of different
lengths, and concluded that there were no speciﬁc
RRM1–RRM2 contacts associated with the binding of
certain substrates, nor do the ﬂexible RNA spacer se-
quences between UGU(U) sites appear to be
accommodated through speciﬁc protein contacts.
Figure 7. Continued
Representative portions of the
1H/
15N TROSY spectra from the two titrations are shown in (c) and (d). In particular, residue C150 in RRM2 is
perturbed by the binding of EDEN15 (c), but not by CUG15 (d). Five TROSY spectra are overlayed in each case representing protein:RNA ratios in
the range 1:0–1:1. (e) Similar overlayed portions of the
1H/
15N TROSY spectrum of T187 showing the limiting CSPs for Cys61 (RRM1) and Cys150
(RRM2) at binding saturation with a series of related RNA sequences containing different U spacers UGU(U)xUGU, where x=1–7. (f) Histogram
plot showing the CSP data from (e) for Cys61 and Cys150 with the CSPs for RRM1 reaching a plateau between x=2–5; longer U spacers (x=6
and 7), or a very short spacer (x=1) result in a reduction in binding afﬁnity for RRM2 but little difference in the shift of Cys61 in RRM1. (g)
Binding isotherms at 298K from ITC studies of T187 with UGU(U)xUGU sequences where x=1, 2 and 6. The shortest sequence (x=1) shows a
biphasic binding behaviour whereas the two other sequences (x=2 and 4) ﬁt to a 1:1 binding model.
Figure 8. Schematic representation of the binding of RRM1, RRM2
and T187 to RNA substrates. (a) EDEN7 is able to accommodate two
RRM1s on adjacent UGU sites, but only a single RRM2 can bind to
the same sequence, suggesting speciﬁcity for a UGUU binding site. (b)
EDEN7 is too short to bind the two RRMs of T187 in tandem, instead
we observe an interaction through RRM1 which could be at either of
the two UGU sites (one shown). (c) Binding of T187 to both sites of
the consensus GRE sequence (EDEN11) with RRM2 bound at the
50-terminal UGUU site. The spacer sequence of 5nt between the
tandem UGU sites results in high afﬁnity binding. (d) Possible inter-
action of full-length CELF1 with a GU-rich substrate with RRM1 and
RRM2 bound as for the consensus sequence in (c); the long linker
between RRM2 and RRM3 permits considerable conformational ﬂexi-
bility in binding a third UGU site up or down stream (position of
arrows), or even to the looped-out spacer sequence between the
RRM1 and RRM2 binding sites.
Table 3. Isothermal titration calorimetry data for the interaction of
CELF1 T187 construct with RNA
RNA sequence Kd (mM) Binding
stoichiometry
UGU 64±2 0.51
UGUUUUGU (x=2) 0.43±0.15 1.27
UGUUUUUUGU (x=4) 0.37±0.15 1.35
UGUUUUUUUGU (x=5) 3.5±0.5 0.91
UGUUUUUUUUGU (x=6) 3.4±0.3 0.89
RRM binding sites underlined.
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bioinformatics analysis, UGUUUGUUUGU, appears to
correspond to the optimum binding site for the tandem
interaction of the ﬁrst two RRMs of full length CELF1
(12,29). As the third RRM of CELF1 has also been
reported to bind (UG)3, this indicates that the preferred
binding site for full length CELF1 likely requires an add-
itional GU-rich motif, either upstream or downstream of
this consensus site (Figure 9d). The poor binding we
observe with T187 and the c-Mos EDEN sequence
(EDEN19: UGUAUGUGUUGUUUUAUGU)i s
surprising since it would appear to contain three optimal
spacings of 2, 3 and 4nt between UGU(U) sites for
binding to the ﬁrst two RRMs. It therefore appears that
in addition to the spacer length, the sequence context also
inﬂuences binding, with certain nucleotides not being
tolerated adjacent to the UGU sites. Our data indicate
that the central G in the 5-nt spacer in EDEN11 can be
replaced by a U without a loss of binding, and both
natural and synthetic high afﬁnity binding sites have
been observed with CUGUC (Figure 2a and e) and GU
GUG spacers (12,25,29). In addition, UGUA repeats do
bind CELF1, but they appear to have somewhat reduced
afﬁnity (7,25). Further study is required to unambiguously
identify the sequence context-dependence for the binding
of RRM1 and RRM2.
The possibility of multiple binding sites within the CUG
CUG RNA sequence precludes an unambiguous deter-
mination of which tri-nucleotide is being recognized.
However, the similarity of the interaction of RRM1 with
both EDEN7 (UGUUUGU) and CUGCUG suggests
that it may be UGY (Y=U or C). However, there are
a number of CELF1 substrates that are rich in GCC
trinucleotides, rather than UGC or CUG, suggesting
that the trinucleotide recognition site could be GCY
(Y=U or C). How CELF1 binds to combination sub-
strates with GCY and UGU sites would also give infor-
mation on the orientation of the RNA in the complex and
possibly help reﬁne the consensus binding sequence.
There is no available crystal structure of T187 bound to
RNA in the cooperative manner we describe, however,
during the review process crystal structures of CELF1
RRM1 and tandem RRM1/RRM2 domains (T187)
bound to UGU sites in 12 and 13nt RNAs have also
shed light on UGU(U) recognition of the individual
RRMs (41). Studies with the T187 construct with
GUUGUUUUGUU (equivalent spacing to EDEN2U in
our analysis) resulted in RRM2–RNA interactions but not
tandem binding of both RRMs to the same nucleotide
sequence. The structures revealed that both RRMs
target UGU(U/G) sequences and recognize the base and
sugar–phosphate backbone of the UG and GU steps of
UGU through a similar set of direct and water-mediated
hydrogen bonds and stacking interactions. Cys61 in
RRM1 and Cys150 in RRM2 are both involved in
hydrogen bonding to the ribose 20-OH of the guanine
within the two tandem UGU(U/G) binding sites.
Speciﬁcity is also achieved by selecting for a G (syn) con-
ﬁguration, with the UG step adopting an unanticipated
left-handed z-helix. Although not observed in the crystal
structures of T187 complexes, NMR and ITC studies of
T187 with the same 12nt RNA indicate that the tandem
interaction of the two RRMs occurs in solution with a
binding afﬁnity >150-fold stronger than for the individual
RRMs. These structures suggest that both RRMs require
a tetra-nucleotide UGU(U/G) motif, however, from our
analysis of binding stoichiometries with short RNA frag-
ments this does not appear to be an absolute requirement
in the case of RRM1, where UGU appears to be sufﬁcient.
Our studies have provided additional insights into the role
of the spacer length in accommodating tandem binding
interactions.
Both of the reported structural studies conﬁrm that the
canonical RRM fold of RRM1 and RRM2 of CELF1
utilizes conserved residues mainly on strands b1 and b3
in UGU(U) recognition, and have shed light on the
tandem interaction of these binding motifs in recognizing
regulatory RNA sequences. Enhanced binding of the
protein to GC rich substrates in muscular dystrophy (31)
has been linked to phosphorylation of Ser28, which lies
close to residues on the RNA binding face of RRM1.
Mutation of Ser28 to Asp enhances the binding of the
protein to these substrates. In fact, in the closest relative
of CELF1 in Drosophila, Bruno (Genbank; AAB58464),
the corresponding Ser has been replaced by Asp, suggest-
ing that this protein has a permanent preference for GC
rich substrates. Further experimentation is required to de-
termine the precise molecular basis of these changes in
RNA sequence speciﬁcities.
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